Viatris Inc
NASDAQ:VTRS
Revenue Breakdown
Breakdown by Geography
Viatris Inc
Breakdown by Segments
Viatris Inc
Total Revenue:
15.4B
USD
|
Net Sales:
15.4B
USD
|
Brands:
9.8B
USD
|
Generics:
5.6B
USD
|
Lipitor ®:
1.6B
USD
|
Norvasc ®:
732.4m
USD
|
Lyrica ®:
556.5m
USD
|
Epipen® Auto-Injectors:
442.2m
USD
|
Viagra ®:
428.8m
USD
|
Celebrex ®:
330.6m
USD
|
Creon ®:
304.9m
USD
|
Effexor ®:
262.9m
USD
|
Zoloft ®:
235.7m
USD
|
Yupelri ®:
220.8m
USD
|
Dymista ®:
200m
USD
|
Xalabrands:
193.2m
USD
|
Influvac ®:
192.4m
USD
|
Amitiza ®:
157m
USD
|
Xanax ®:
154.8m
USD
|